NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘ARMO BioSciences’

30 May 2014

KPCB, OrbiMed, DAG renew commitment to ARMO BioSciences in $30m Series B

medical cell disease virus health A trio of venture capital investors have reaffirmed their commitment to ARMO BioSciences by backing a $30m Series B financing round.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015